Magyar Aneszteziológiai és Intenzív Terápiás Társaság 4th World Congress: World Institute of Pain - WIP Rendezvény vége: 2007.09.30. Szervező: Ms. Erica Rieman Munkahely neve: c/o Kenes International Címe: 17 Rue du Cendrier, PO Box 1726
CH-1211 Geneva 1
Switzerland Tel: +41 22 908 0488 Fax: +41 22 732 2850 E-mail: erieman@kenes.com Helyszín: Budapest, Hungary -Budapest Sportarena (1143 Budapest, Stefania ut 2.) A rendezvény Web oldala: http://www.kenes.com/wip/wel.asp WIP combined focus on participant-friendly yet intense educational activities together with “hands-on” courses, has yielded the development of novel interventional techniques for the management of pain. At the same time we have fostered consensus building amongst pain experts on the effectiveness of existing techniques and on avenues for further improvements in therapeutic performances.
Magyar Dermatológiai Társulat ILDS webinar (2021.04.14.) "Lessons Learned about the Integrated Care Management of Skin Patients Through the Lens of Atopic Dermatitis” Rendezvény vége: 2021.04.14. Helyszín: online, A rendezvény Web oldala: https://globalskin.org/index.php?option=com_civicrm&task=civicrm/event/info&reset=1&id=51 Dear Colleagues,
Magyar Dermatológiai Társulat 10th World Congress of Melanoma / 17th EADO Congress 2021 in Rome Rendezvény vége: 2021.04.17. Helyszín: Italy, 00144 Rome, Roma Convention Center, La Nuvola Viale Asia snc A rendezvény Web oldala: https://worldmelanoma2021.com/ All those interested in presenting abstracts at the virtual 10th World Congress of Melanoma and 17th EADO Congress are invited to submit their work to the Programme Committee for review.
Kapcsolódó linkek (1) Kapcsolódó dokumentumok (2)
Magyar Dermatológiai Társulat IPC Congress Symposia (online, 2021.04.17.) - Challenging cases in psoriasis: A focus on COVID-19, biologics and adverse events Rendezvény vége: 2021.04.17. Helyszín: online, A rendezvény Web oldala: https://www.psoriasiscouncil.org/agenda_radla2021.htm Challenging cases in psoriasis: A focus on COVID-19, biologics and adverse events
